Modeling Low Muscle Mass Screening in Hemodialysis Patients

Area of Science:

• Nephrology
• Geriatrics
• Radiology

Background:

• Sarcopenia diagnosis in hemodialysis patients is crucial but challenging due to limited CT scanner availability.
• Computed tomography (CT) accurately measures muscle mass, essential for diagnosing sarcopenia.

Purpose of the Study:

• To develop a bedside prediction model for low muscle mass, defined by psoas muscle mass index (PMI), in hemodialysis patients.
• To facilitate early sarcopenia screening and intervention in this vulnerable population.

Main Methods:

• A logistic regression model was developed using clinical data from 441 hemodialysis patients.
• Ten variables including grip strength, sex, height, and blood pressure were identified as predictors.
• Model performance was validated in a separate group of 178 patients, calculating AUC, sensitivity, and specificity.

Main Results:

• The model identified ten key predictors for low muscle mass (PMI).
• In the development group, the adjusted AUC was 0.81, with 60% sensitivity and 87% specificity.
• In the validation group, the adjusted AUC was 0.73, with 64% sensitivity and 82% specificity.

Conclusions:

• The developed bedside model effectively predicts low muscle mass in hemodialysis patients.
• This tool supports sarcopenia prophylaxis and timely intervention decisions.
• It offers a practical approach to skeletal muscle assessment in dialysis facilities.